🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 6 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/07/2024 10,77 11,07 10,76 10,80 +0,56% 2,88% 3.579.800
25/07/2024 10,75 10,87 10,67 10,74 -0,09% 1,86% 3.700.000
24/07/2024 10,93 11,01 10,75 10,75 -2,36% 2,38% 3.777.800
23/07/2024 11,10 11,18 11,00 11,01 -1,08% 1,62% 2.693.800
22/07/2024 11,02 11,17 10,94 11,13 +1,18% 2,13% 2.973.600
19/07/2024 11,08 11,10 10,92 11,00 -0,99% 1,62% 4.046.100
18/07/2024 11,29 11,40 11,08 11,11 -1,24% 2,87% 6.018.500
17/07/2024 11,51 11,59 11,13 11,25 -3,10% 4,00% 4.400.100
16/07/2024 11,47 11,72 11,45 11,61 +0,96% 2,35% 5.669.900
15/07/2024 11,35 11,57 11,31 11,50 +1,32% 2,29% 6.986.100
12/07/2024 11,29 11,37 11,11 11,35 +0,98% 2,30% 5.102.000
11/07/2024 11,45 11,53 11,19 11,24 -0,09% 2,93% 6.692.400
10/07/2024 10,87 11,26 10,87 11,25 +3,88% 3,59% 7.284.300
09/07/2024 10,68 10,85 10,65 10,83 +1,03% 1,87% 4.661.300
08/07/2024 10,71 10,88 10,61 10,72 +0,66% 2,52% 4.748.700
05/07/2024 10,48 10,67 10,33 10,65 +1,62% 3,24% 4.281.700
03/07/2024 10,66 10,68 10,45 10,48 -0,76% 2,16% 2.350.600
02/07/2024 10,83 10,83 10,48 10,56 -2,49% 3,28% 4.543.400
01/07/2024 10,50 10,89 10,50 10,83 +2,46% 3,71% 4.128.800
28/06/2024 10,58 10,75 10,44 10,57 +0,00% 2,93% 11.362.900
27/06/2024 10,53 10,62 10,41 10,57 +0,00% 2,04% 4.480.300
26/06/2024 10,76 10,82 10,54 10,57 -2,40% 2,60% 3.250.000
25/06/2024 10,87 11,02 10,73 10,83 -0,73% 2,67% 4.397.400
24/06/2024 10,71 10,99 10,70 10,91 +2,06% 2,71% 10.111.400
21/06/2024 10,90 10,92 10,57 10,69 -1,02% 3,21% 19.324.100
20/06/2024 10,80 10,90 10,74 10,80 -0,37% 1,44% 5.166.500
18/06/2024 10,74 10,87 10,68 10,84 +1,12% 1,72% 3.955.300
17/06/2024 10,64 10,82 10,60 10,72 +0,28% 2,02% 2.693.700
14/06/2024 10,71 10,78 10,59 10,69 -1,11% 1,77% 2.802.700
13/06/2024 10,76 10,92 10,71 10,81 -0,18% 2,00% 2.893.800